Vitiligo is a common condition causing loss of pigmentation in patches of skin. Although vitiligo may be more noticeable in darker skin, it can have a considerable effect on psychological wellbeing in anyone who is affected by the condition.
Many previous clinical trials of treatments for vitiligo have been small or poorly designed. There has also been wide variation in the outcome measures used to measure the effects of vitiligo treatments. We have addressed these issues by:
- Examining whether UV-light (used at home) and topical steroids help vitiligo.
Maxine Whitton MBE, shares her experience of taking part in one of our vitiligo trials.
- Training on how to use hand-held narrowband ultraviolet light (NB-UVB) devices safely
- A patient-rated outcome measure assessing the acceptability of treatment response.
A patient-rated outcome measure assessing the acceptability of treatment response.
Developing a Core Outcome Set for vitiligo - International Initiative for outcomes for vitiligo trials (INFO)
Training on how to use hand-held narrowband ultraviolet light (NB-UVB) devices safely.
A training resource to demonstrate how to perform an Minimal Erythema Dose (MED) test.
Maps of systematic reviews on vitiligo by topic
Handbook for using NB-UVB Light Devices and topical corticosteroids A guide for local medical teams developing protocols for home treatment of vitiligo.
The 糖心原创 Applied Health Research Building University Park, Nottingham NG7 2RD
telephone: +44 (0) 115 84 68631 email: cebd@nottingham.ac.uk